Fangfang Wang
#37 GuoXue Xiang Street
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The role of KPNA3 in multiple myeloma: implications for targeting nuclear import.
Journal: Apoptosis : an international journal on programmed cell death
Published: December 04, 2025
Rho-related GTP-binding protein RhoE (RND3) regulates multiple myeloma bone disease.
Journal: Cancer cell international
Published: June 30, 2025
Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.
Journal: International journal of cancer
Published: April 04, 2025
LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma.
Journal: Biochemical pharmacology
Published: January 18, 2025
The mitochondrial protease ClpP is a promising target for multiple myeloma treatment.
Journal: Biochemical pharmacology
Published: November 07, 2024
Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide.
Journal: British journal of haematology
Published: December 08, 2023
RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor.
Journal: Cancer letters
Published: September 01, 2023
Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma.
Journal: Life sciences
Published: June 23, 2023
Single-cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition.
Journal: The journal of gene medicine
Published: April 27, 2023
ALCAM regulates multiple myeloma chemoresistant side population.
Journal: Cell death & disease
Published: October 19, 2021
A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma.
Journal: Cancer medicine
Published: October 10, 2021
Last Updated: 09/26/2026